MedPath

Multicenter cohort study on the relation between soluble PD-L1 and prognosis of age-related EBV-associated lymphoproliferative disorders.

Not Applicable
Conditions
EBV-associated diffuse large B-cell lymphoma
Registration Number
JPRN-UMIN000022932
Lead Sponsor
ational Hospital Organization
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

The cases were diagnosed as immunodeficiency-associated lymphoproliferative disorders, which are defined by WHO classification 4th ed. 2008.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the relation between soluble PD-L1 and IPI in EBV-associated LPD.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath